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Introduction 
Because laboratory testing has a serious impact on 
clinical decision making the main task of laborato-
ry professionals is to ensure high quality of test re-
sults. Implementation of high-quality test tubes 
can assure reliable test results and optimize labo-
ratory work-flow through reducing the need for 
blood specimen re-collection as well as shorten-
ing time needed for sample preparation. Introduc-
ing new test tubes into routine application re-
quires their prior verification (1). The procedure is 
well defined in Clinical and Laboratory Standards 
Institute (CLSI) guideline GP-34A (2).
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Abstract
Introduction: The aim was to evaluate the BD Barricor tubes by comparison with the BD Rapid Serum Tubes (RST) through measuring 25 analytes 
and monitoring sample stability after 24 hours and 7 days.
Materials and methods: Samples of 52 patients from different hospital departments were examined. Blood was collected in BD RST and BD 
Barricor tubes (Becton, Dickinson and Company, Franklin Lakes, USA). Analytes were measured by Beckman Coulter AU 480 (Beckman Coulter, Brea, 
USA), Dimension EXL (Siemens Healthcare Diagnostics, Newark, USA) and ARCHITECT i2000SR (Abbott Diagnostics, Lake Forest, USA). Between-tube 
comparison for each analyte was performed, along with testing analyte stability after storing samples at 4 °C.
Results: BD Barricor tubes showed unacceptable bias compared to BD RST tubes for potassium (K) (- 4.5%) and total protein (4.4%). Analyte stability 
after 24 hours was acceptable in both tested tubes for most of analytes, except for glucose, aspartate aminotransferase (AST) and lactate dehydro-
genase (LD) in BD Barricor and free triiodothyronine in BD RST sample tubes. Analyte stability after 7 days was unacceptable for sodium, K, calcium, 
creatine kinase isoenzyme MB, AST, LD and troponin I in both samples; additionally for glucose, alkaline phosphatase and albumin in BD Barricor.
Conclusion: All analytes, except K and total protein, can be measured interchangeably in BD RST and BD Barricor tubes, applying the same reference 
intervals. For most of the analytes, sample re-analysis can be performed in both tubes after 24 hours and 7 days, although BD RST tubes show better 
7-day analytes stability over BD Barricor tubes.
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For a long-time serum was considered the stand-
ard sample for analysis in clinical chemistry (3). In 
recent years plasma has become the preferable 
sample, especially for emergency laboratory ana-
lytes, because of time-saving advantages and low-
er risk of haemolysis (3-5). 
BD Rapid Serum Tubes (RST) (Becton, Dickinson 
and Company, Franklin Lakes, USA) are vacuum 
tubes containing a thrombin-based clot activator 
and polymer gel which provides rapid serum sep-
aration and makes them suitable for emergency 
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analyses (6). In BD RST tubes, under centrifugation 
conditions, gel becomes liquid and moves be-
tween plasma and cells. A thick gel barrier starts 
forming within 2 minutes resulting in trapping 
cells at the bottom of the plasma compartment. 
However, those tubes are susceptible to latent clot 
formation when collected from patients receiving 
high doses of anticoagulants, consequently delay-
ing in reporting patient results (6). In order to im-
prove turnaround time (TAT) and specimen quali-
ty, in 2016 the same company offered Barricor 
tubes (Becton, Dickinson and Company, Franklin 
Lakes, USA). Instead of polymer gel, these tubes 
contain a mechanical, chemically inert separator, 
and the interior tube wall coated with lithium hep-
arin anticoagulant. Both, the tube stopper and the 
mechanical separator are lubricated with a sili-
cone-based surfactant to facilitate product assem-
bly. As the mechanical separator remains open 
during the entire centrifugation process, it enables 
efficient cell flow out of the plasma providing a 
much cleaner sample with less cell debris. Accord-
ing to the manufacturer, these tubes can with-
stand a relatively high centrifugal force (up to 
5000xg), so as declared, a plasma sample can be 
obtained after a three-minute tube centrifugation 
at 4000xg ensuring a clean, high-quality sample, 
together with improved sample stability (7,8).
Serum and heparinized plasma specimens are 
considered to be equivalent for analysing many 
analytes, and it is not uncommon for hospital-
based laboratories to receive plasma and serum 
specimens interchangeably (6). However, signifi-
cant differences in the results obtained for some 
analytes are well documented (6,9). 
The hypothesis of this study was that BD RST and 
BD Barricor tubes may be used interchangeably 
for analysing biochemistry and immunochemistry 
emergency laboratory panel parameters without 
changing the reference intervals, with the excep-
tion of potassium, as declared in manufacturer’s 
specification. Furthermore, we assumed that BD 
Barricor tubes ensure satisfactory plasma sample 
stability comparable to BD RST serum samples. 
The aims of this study were: I) to evaluate if the an-
alytes’ results provided by BD Barricor are compa-
rable to the BD RST results and II) compare the 
sample stability difference, in both tubes at two 
time points (24 hours and 7 days), with the initial 
time.
Materials and methods 
Subjects
Specimen collection was performed at the Osijek 
University Hospital from May to June 2017. Patients 
over 18 years old were randomly selected from dif-
ferent hospital departments (Table 1). Such a pa-
tient selection provided a real condition simulation 
and an adequate sample size for obtaining patients’ 
results with notably high and low values. Haemo-
lysed or lipemic samples after centrifugation were 
considered as exclusion criteria. Finally, 52 patients 
with an average age of 63 (range from 20 to 87 
years) were included, 27 males and 25 females. Any 
test result that was below the limit of detection 
(LoD) was excluded from further calculations. 
Department Female(N / total)
Department of Nephrology 3 (6)
Department of Cardiovascular Disease 6 (12)
Department of Gastroenterology and 
Hepatology 3 (6)
Department of Endocrinology 3 (6)
Department of Nuclear Medicine and Radiation 
Protection 3 (5)
Department of Emergency Medicine 7 (17)
Table 1. Patients included in the study
Informed consent was obtained from all patients 
enrolled in this study. The study was approved by 
the Ethics Committee and was in accordance with 
the Declaration of Helsinki.
Blood sampling
Venipuncture was performed exclusively by one 
laboratory technician in the morning hours be-
tween 7.00 AM and 9.00 AM in the fasting state ac-
https://doi.org/10.11613/BM.2020.030704 Biochem Med (Zagreb) 2020;30(3):030704 
  3
Mandić S. et al. Evaluation of the BD Barricor vacutainer tubes
cording to the proposed recommendations, ex-
cept for patients admitted to the emergency de-
partment, where blood sampling was performed 
at the time of patient’s arrival but limited to the 
morning hours from 7.00 AM to 12.00 AM (10). 
Blood sampling was performed randomly into two 
blood collection tubes: reference tube - BD RST (5 
mL, Ref. 368774) and comparison tube - BD Barri-
cor tube (4.5 mL, Ref. 65030). Immediately after 
blood collection, tubes were gently inverted, RST 
tube by five complete inversions and BD Barricor 
tube by eight complete inversions as recommend-
ed by the manufacturer. Tubes were transported 
in an upright position at room temperature to the 
emergency laboratory by the laboratory techni-
cian.
Methods
Blood samples were centrifuged according to the 
manufacturer recommendation within 20 minutes 
from blood collection in a swing bucket centrifuge 
at room temperature: RST tubes for 10 minutes at 
2000xg using Rotina 380R (Hettich, Tuttlingen, 
Germany) and Barricor tubes for 3 minutes at 
4000xg using Allegra 2IR Centrifuge (Beckman 
Coulter, Brea, USA) (8). The RST centrifugation 
mode was in agreement with the daily routine in 
our laboratory. For each tube, following preanalyt-
ical requirements were monitored by the labora-
tory technician, according to the recommenda-
tions: incorrect filling of collection tubes (not with-
in ± 10% of the stated draw volume), barrier for-
mation, haemolysis and fibrin mass or fibrin strand 
presence (1). These characteristics were monitored 
after placing both the reference and the compari-
son tube in an upright position side by side.
Primary tubes were used for measuring most of 
the analytes, while aliquots were used for troponin 
I (TnI), myoglobin, thyroid stimulating hormone 
(TSH), free triiodothyronine (fT3) and free thyrox-
ine (fT4) measurements. Sample aliquoting was 
performed immediately after centrifugation for 
the purpose of initial time sample stability meas-
urement. Likewise, aliquots were taken again from 
the primary tubes at two time points for the pur-
pose of sample retesting, following the predefined 
storage periods (24 hours and 7 days). The follow-
ing analytes were measured in primary tubes us-
ing Beckman Coulter AU 480 analyser (Beckman 
Coulter, Brea, USA) with reagents from the same 
company, according to the manufacturer’s specifi-
cation: sodium (Na), potassium (K), calcium (Ca), 
chloride (Cl), urea, creatinine, glucose, total pro-
tein, albumin, aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), alkaline phos-
phatase (ALP), lactate dehydrogenase (LD), biliru-
bin, creatine kinase (CK), creatine kinase isoen-
zyme MB (CK-MB), amylase, gamma-glutamyl-
transferase (GGT), uric acid and C-reactive protein 
(CRP). All the above-mentioned analytes except 
CRP and electrolytes were measured with spectro-
photometric methods. C - reactive protein was de-
termined with an immunoturbidimetric method 
and electrolytes (Na, K, Cl) were determined by in-
direct potentiometry. All samples were also tested 
for lipemia/turbidity, icterus and haemolysis (LIH) 
interferences on the same analyser. Troponin I and 
myoglobin were measured using Dimension EXL 
with LM analyser (Siemens Healthcare Diagnostics, 
Newark, USA) based on a luminescent oxygen 
channelling assay (LOCI) technology. Finally, TSH, 
fT3 and fT4 were measured using ARCHITECT 
i2000SR (Abbott Diagnostics, Lake Forest, USA) an-
alyser with a chemiluminescent microparticle im-
munoassay (CMIA) method. All measurements 
were carried out following our laboratory quality 
assurance procedures. Once the tests were per-
formed, only primary tubes were stored at 4 °C. All 
analytes were retested at two time points (24 
hours and 7 days) in the same way as previously 
described. Analytical performance specifications 
for tested parameters were all based on biological 
variation (11,12).
Statistical analysis
Statistical analysis was performed using MedCalc 
for Windows, version 12.4.0.0. (MedCalcSoftware, 
Mariakerke, Belgium). The normality of distribution 
of investigated parameters was tested using the 
Kolmogorov-Smirnov test. Results are presented in 
accordance to their distribution: as average values 
and standard deviations (SD) for normally distrib-
uted parameters or median values and interquar-
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tile ranges (IQR) for non-normally distributed pa-
rameters. A paired t-test or a Wilcoxon test were 
run to calculate the differences between meas-
ured parameters. P value less than 0.05 (P < 0.05) 
was considered statistically significant. The bias for 
each analyte for between-tube comparison was 
calculated according to the formula: [(comparison 
tube result – reference tube result) / reference 
tube result] x 100, where BD RST represents the 
reference tube and BD Barricor the comparison 
tube. Average of all calculated results differences 
between the reference and comparison tube for 
each analyte represents the mean bias. The mean 
bias was compared to the current desirable speci-
fications for inaccuracy that were previously calcu-
lated according to the formula as follows: B < 
(CVw2+CVb2)1/2, where CVw stands for intraindividu-
al variation and CVb for interindividual variation 
(12,13). Differences between all measured parame-
ters over time in the same tube type were calcu-
lated as follows: [(time point X result – time point 0 
result) / time point 0 result] x 100, where X stands 
for 24 hours or 7 days, respectively. The mean dif-
ference for each analyte in the same tube over 
time (24 hours or 7 days) was compared to the cur-
rent specifications for desirable allowable impreci-
sion that was previously calculated according to 
the formula as follows: I < 0.5CVw2 (13). Analytes’ 
CVw and CVb were taken from European Federa-
tion of Clinical Chemistry and Laboratory Medi-
cine (EFLM) Biological Variation Database, and if 
the data was not listed there (Ca, CK-MB, uric acid, 
bilirubin, TnI and myoglobin), data was taken from 
the Westgard’s database (11,13). Results of the 
mean biases between tubes and mean differences 
over time were considered acceptable when the 
calculated mean bias or difference for comparison 
did not exceed the desirable specification for inac-
curacy or the desirable specification for allowable 
imprecision (11,12). Accordingly, all measured dif-
ferences that exceeded the above-mentioned 
specifications were considered unacceptable. 
Passing-Bablok regression was performed for the 
results comparison. Results were presented with 
the regression equation (y = a + bx) with the cor-
responding 95% confidence intervals (CI), where 
intercept (a) represents the constant and slope (b) 
the proportional difference. If the 95% CI for inter-
cept includes value 0 there is no constant differ-
ence between the measurements. Respectively, if 
the 95% CI for slope includes value 1 there is no 
proportional difference between measurements.
Results
Visual inspection of analysed tubes (N = 52 BD RST 
and N = 52 BD Barricor) showed that tubes were 
adequately filled to their acceptable volume with 
the barrier formation. Furthermore, all tubes con-
tained no fibrin mass or fibrin strands. No visible 
haemolysis was observed, which was later con-
firmed through routinely assessment of LIH on AU 
480 analyser. 
A few observed results for CK-MB, TnI, TSH, fT3 
and fT4 parameters were below the LoD and these 
results were not utilized in any further calculations. 
Therefore, statistical analysis for listed analytes 
was carried out with a smaller data set (CK-MB: N = 
35; TnI: N = 23; TSH: N = 49; fT3: N = 45; fT4: N = 49). 
Table 2 summarizes the baseline results for all ana-
lytes observed in both investigated tubes, the BD 
RST as a reference tube, and the BD Barricor as a 
comparison tube, along with the observed pa-
tients’ results for each analyte and a correspond-
ing sample size. Although 12 analytes (K, Ca, Cl, CK, 
ALP, GGT, uric acid, total protein, CRP, TnI, TSH and 
fT3) showed a statistically significant difference 
between tested tubes, for most analytes the calcu-
lated bias was within the desirable specifications 
for inaccuracy based on biological variation. Unac-
ceptable bias between investigated tubes were 
obtained for K (- 4.5%) and total protein (4.4%), 
where calculated bias exceeded the predefined 
value of desirable bias (current desirable specifica-
tions for inaccuracy) (1.5% for K and 1.3% for total 
protein). Passing-Bablok regression did not show 
significant differences for most of the analytes. 
However, a systematic difference was observed for 
ALP, while both systematic and proportional dif-
ferences were observed for LD, GGT, total protein, 
albumin and fT4.
The concentration changes over time in both 
tubes after 24 hours and after 7 days were com-
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BD RST BD Barricor P Bias (%)
Desirable 
bias (%)
PB 95% CI 
slope
PB 95% CI 
intercept
Sodium, 
mmol/L 52 128-148 137 ± 3 137 ± 3 0.280 0.07 0.30 1.00 to 1.00 0.00 to 0.00
Potassium, 
mmol/L 52 2.8-6.5 4.4 ± 0.6 4.2 ± 0.6 < 0.001 - 4.47 1.47 0.86 to 1.00 - 0.20 to 0.41
Calcium, 
mmol/L 52 1.86-2.54 2.22 ± 0.16 2.20 ± 0.15 0.001 - 0.58 0.82 0.87 to 1.00 - 0.01 to 0.27
Chloride, 
mmol/L 52 92-120 104 ± 5 103 ± 5 0.005 0.22 0.43 1.00 to 1.00 0.00 to 0.00
Glucose, 
mmol/L 52 2.8-30.7 6.7 (6.2-7.6) 6.9 (6.2-7.7) 1.000 0.41 2.39 0.97 to 1.00 0.00 to 0.25
CK, U/L 52 11-2574 89 (56-132) 90 (56-131) 0.003 0.89 8.90 0.99 to 1.00 - 1.00 to 0.17
CK-MB, U/L 35 10-374 18 (13-20) 16 (13-19) 0.784 - 1.95 7.80 1.00 to 1.01 - 0.94 to 0.00
AST, U/L 52 10-231 29 (20-36) 29 (20-36) 0.183 0.14 5.63 0.95 to 1.00 0.00-1.61
ALT, U/L 52 3-200 24 (19-30) 25 (20-28) 0.741 2.70 7.75 0.96 to 1.00 0.00 to 1.01
ALP, U/L 52 32-498 75 (65-84) 74 (65-82) < 0.001 - 2.43 6.10 0.96 to 0.99 - 1.64 to 1.29
LD, U/L 52 100-1369 211 (173-256) 213 (188-262) 0.371 1.66 3.38 0.92 to 0.98 5.06 to 20.93
GGT, U/L 52 7-1070 31 (25-36) 30 (24-34) < 0.001 - 3.21 10.56 0.97 to 0.98 - 0.61 to -0.13
Urea, mmol/L 52 2.0-30.9 7.2 (6.3-8.5) 7.1 (6.3-8.4) 0.930 0.11 6.15 1.00 to 1.01 - 0.05 to 1.25
Creatinine, 
μmol/L 52 44-552 89 (79-104) 91 (80-106) 0.070 1.03 3.75 0.99 to 1.01 - 0.49 to 2.12
Amylase, U/L 52 24-979 60 (51-71) 61 (51-71) 0.116 - 0.45 7.73 1.00 to 1.00 0.00 to 0.00
Uric acid, 
μmol/L 52 86-930 387 ± 163 388 ± 165 0.007 0.27 4.87 1.00 to 1.02 - 4.14 to 1.00
Total protein, 
g/L 52 48.8-82.8 66.4 ± 7.7 69.1 ± 7.2 < 0.001 4.39 1.32 0.88 to 0.97 4.60 to 10.88
Albumin, g/L 52 22.1-48.4 37.4 ± 6.7 37.4 ± 6.4 0.760 0.12 1.43 0.93 to 0.98 0.71 to 2.51
CRP, mg/L 52 0.3-182.4 6.6 (3.1-12-5) 6.6 (3.0-12.3) < 0.001 0.19 23.47 0.98 to 1.00 0.00 to 0.07
Bilirubin, 
μmol/L 52 6-314 12 (10-14) 12 (10-14) 0.091 0.02 8.95 1.00 to 1.00 0.00 to 0.00
TnI, ng/L 23 18-49,918 2903 (158-5386)
2972 
(172-5536) 0.022 4.10 16.32 1.00 to 1.03 0.00 to 0.02
Myoglobin, 
μg/L 52 14-855 61 (50-81) 60 (49-80) 0.641 - 0.22 8.20 0.99 to 1.02 - 1.40 to 0.43
TSH, mIU/L 49 0.07-56.8 1.71 (0.927-2.55)
1.70 
(0.934-2.62) 0.038 2.26 8.91 1.00 to 1.02 0.00 to 1.03
fT3, pmol/L 45 2.42-21.15 3.90 (3.44-4.27)
3.84 
(3.42-4.50) 0.034 1.63 4.39 0.99 to 1.11 - 0.39 to 0.10
fT4, pmol/L 49 7.29-45.34 13.40 (12.98-14.28)
13.40 
(12.95-14.06) 0.366 - 0.27 3.56 1.01 to 1.07 - 1.12 to -0.22
Data are presented as mean ± standard deviation, and median (interquartile range). %Bias - difference between the compared 
tube results and the reference tube results. PB - Passing-Bablok. CI - confidence interval. CK - creatine kinase. CK-MB - creatine 
kinase isoenzyme MB. AST - aspartate aminotransferase. ALT - alanine aminotransferase. ALP - alkaline phosphatase. LD - lactate 
dehydrogenase. GGT – gamma-glutamyltransferase. CRP - C-reactive protein. TnI - troponin I. TSH - thyroid-stimulating hormone. fT3 - 
free triiodothyronine. fT4 - free thyroxine. P value < 0.05 was considered statistically significant.
Table 2. Baseline time-point comparison of analytes collected in the BD RST tube and the BD Barricor tube
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pared to the current specifications for desirable al-
lowable imprecision, and are shown in Table 3 (af-
ter 24 hours) and Table 4 (after 7 days). Most of the 
tested analytes showed satisfactory stability dur-
ing a 24-hour storage period and met the prede-
fined criteria based on the current specifications 
for desirable allowable imprecision. Unacceptable 
differences were noted for glucose, AST and LD 
measured in plasma specimens (BD Barricor), as 
well as for fT3 measured in serum specimens (BD 
RST), showing an unacceptable concentration 
change after a 24-hour storage period (Table 3). 
Less satisfactory results were obtained examining 
analytes’ long-term stability. Unacceptable differ-
ences after 7-day storage were obtained for Na, K, 
Ca, CKMB, AST, LD and TnI in both samples, while 
for glucose, ALP and albumin in plasma samples 
only (Table 4). Analytical coefficients of variation of 
all investigated analytes are summarized in the 
Supplementary table.
Analyte, 
unit N BD RST 0’ BD RST 24 h
Imprecision 









mmol/L 52 137 ± 3 137 ± 3 0.10 137 ± 3 137 ± 3 0.01 0.25
Potassium, 
mmol/L 52 4.4 ± 0.6 4.4 ± 0.7 1.74 4.2 ± 0.6 4.2 ± 0.6 1.76 2.05
Calcium, 
mmol/L 52 2.22 ± 0.16 2.22 ± 1.18 0.30 2.20 ± 0.15 2.21 ± 0.16 0.32 1.05
Chloride, 
mmol/L 52 104 ± 5 104 ± 5 - 0.05 103 ± 5 104 ± 5 - 0.24 0.55
Glucose, 
mmol/L 52 6.7 (6.2-7.6) 6.7 (6.2-7.6) - 0.92 6.9 (6.2-7.7) 6.6 (5.9-7.3) - 3.88 2.55
CK, U/L 52 89 (56-132) 87 (57-131) 0.06 90 (56-131) 86 (55-128) - 2.94 8.00
CK-MB, U/L 35 18 (13-20) 15 (13-19) - 7.73 16 (13-19) 11 (10-16) 4.26 9.90
AST, U/L 52 29 (20-36) 29 (21-36) 1.83 29 (20-36) 31 (22-37) 4.85 4.75
ALT, U/L 52 24 (19-30) 24 (19-30) 1.88 25 (20-28) 25 (19-30) 1.76 5.20
ALP, U/L 52 75 (65-84) 75 (65-84) - 0.81 74 (65-82) 74 (62-79) - 1.77 2.70
LD, U/L 52 211 (173-256) 210 (170-249) - 1.25 213 (188-262) 223 (201-261) 2.89 2.60
GGT, U/L 52 31 (25-36) 31 (25-38) 1.23 30 (24-34) 30 (24-36) 0.80 4.40
Urea, 
mmol/L 52 7.2 (6.3-8.5) 7.3 (6.4-8.4) 0.58 7.1 (6.3-8.4) 7.2 (6.4-8.4) 0.13 6.95
Creatinine, 
μmol/L 52 89 (79-104) 92 (79-106) 1.22 91 (80-106) 92 (80-104) 0.11 2.25
Amylase, U/L 52 60 (51-71) 61 (51-71) - 0.29 61 (51-71) 60 (51-70) - 0.78 3.30
Uric acid, 
μmol/L 52 387 ± 163 387 ± 166 0.01 388 ± 165 388 ± 164 0.17 4.30
Total 
protein, g/L 52 66.4 ± 7.7 66.5 ± 7.7 0.20 69.1 ± 7.2 69.0 ± 6.8 - 0.14 1.30
Albumin, g/L 52 37.4 ± 6.7 37.2 ± 6.7 - 0.49 37.4 ± 6.4 37.2 ± 6.4 - 0.48 1.30
CRP, mg/L 52 6.6 (3.1-12-5) 6.5 (3.0-12.6) - 0.39 6.6 (3.0-12.3) 6.3 (3.1-12.5) - 0.90 16.75
Bilirubin, 
μmol/L 52 12 (10-14) 12 (10-14) - 3.40 12 (10-14) 12 (10-14) - 2.66 10.90
Table 3. Analytes stability comparison after a 24-hour storage period collected in the BD RST tube and the BD Barricor tube
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Table 3. Continued.
Analyte, 
unit N BD RST 0’ BD RST 24 h
Imprecision 








TnI, ng/L 23 2903 (158-5386) 2433 (157-5820) - 2.71 2972 (172-5536)
2790 
(172-5793) - 0.44 7.03
Myoglobin, 
μg/L 52 61 (50-81) 60 (48-79) - 0.59 60 (49-80) 58 (47-79) - 0.88 7.00
TSH, mIU/L 49 1.71 (0.927-2.55) 1.70 (0.873-2.61) - 2.10 1.70 (0.934-2.62)
1.69 
(0.922-2.63) 0.60 7.95
fT3, pmol/L 45 3.90 (3.44-4.27) 3.96(3.49-4.46) 3.25 3.84 (3.42-4.50)
4.07 
(3.51-4.55) 1.20 3.00







Data are presented as mean ± standard deviation, and median (interquartile range).  PB - Passing-Bablok. CI - confidence interval. 
CK - creatine kinase. CK-MB - creatine kinase isoenzyme MB. AST - aspartate aminotransferase. ALT - alanine aminotransferase. 
ALP - alkaline phosphatase. LD - lactate dehydrogenase. GGT – gamma-glutamyltransferase. CRP - C-reactive protein. TnI - troponin I. 
TSH - thyroid-stimulating hormone. fT3 - free triiodothyronine. fT4 - free thyroxine.
Analyte, 
unit N BD RST 0
BD RST 7 
days
Imprecision 
(%) BD Barricor 0







mmol/L 52 137 ± 3 138 ± 3 0.50 137 ± 3 138 ± 4 0.30 0.25
Potassium, 
mmol/L 52 4.4 ± 0.6 4.6 ± 0.7 4.76 4.2 ± 0.6 4.4 ± 0.7 7.20 2.05
Calcium, 
mmol/L 52 2.22 ± 0.16 2.24 ± 0.17 1.16 2.20 ± 0.15 2.23 ± 0.15 1.11 1.05
Chloride, 
mmol/L 52 104 ± 5 104 ± 5 0.38 103 ± 5 104 ± 5 - 0.04 0.55
Glucose, 
mmol/L 52 6.7 (6.2-7.6) 6.7 (6.2-7.4) - 1.39 6.9 (6.2-7.7) 5.8 (5.0-6.5) - 19.3 2.55
CK, U/L 52 89 (56-132) 86 (56-136) - 0.75 90 (56-131) 84 (56-136) - 1.56 8.00
CK-MB, U/L 35 18 (13-20) 16 (12-19) - 12.3 16 (13-19) 13 (12-18) - 17.9 9.90
AST, U/L 52 29 (20-36) 30 (23-37) 5.22 29 (20-36) 33 (26-39) 13.2 4.75
ALT, U/L 52 24 (19-30) 24 (18-27) - 4.64 25 (20-28) 24 (19-30) - 1.83 5.20
ALP, U/L 52 75 (65-84) 76 (63-81) - 0.96 74 (65-82) 68 (59-75) - 7.37 2.70
LD, U/L 52 211 (173-256) 188 (158-239) - 8.86 213 (188-262) 278 (234-299) 25.6 2.60
GGT, U/L 52 31 (25-36) 32 (25-38) 0.88 30 (24-34) 31 (25-41) 3.90 4.40
Urea, 
mmol/L 52 7.2 (6.3-8.5) 7.3 (6.4-8.4) 2.13 7.1 (6.3-8.4) 7.3 (6.4-8.6) 1.67 6.95
Creatinine, 
μmol/L 52 89 (79-104) 88 (80-103) 0.34 91 (80-106) 88 (80-103) 1.12 2.25
Amylase, 
U/L 52 60 (51-71) 60 (52-71) - 0.56 61 (51-71) 60 (53-70) - 0.48 3.30
Uric acid, 
μmol/L 52 387 ± 163 359 (327-435) 0.81 388 ± 165 357 (328-424) 0.13 4.30
Table 4. Analytes stability comparison after a 7-day storage period collected in the BD RST tube and the BD Barricor tube
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Discussion
This study evaluated BD Barricor tubes in relation 
to BD RST tubes in terms of test results compari-
son and analyte stability. Our results indicate that 
BD Barricor tube represents an acceptable alterna-
tive for BD RST tubes, except for measuring K and 
total protein. Analyte stability over a 24-hour stor-
age period was acceptable for most analytes in 
both tubes, except for glucose, AST and LD in BD 
Barricor tubes and for fT3 in BD RST tubes. Stabili-
ty of 15 analytes (Cl, CK, ALT, GGT, urea, creatinine, 
amylase, uric acid, total protein, CRP, bilirubin, my-
oglobin, TSH, fT3 and fT4), over a 7-day storage 
period, was acceptable in both tubes, while three 
analytes (glucose, albumin and ALP) showed bet-
ter 7-day stability in BD RST tubes.
In recent years, only few BD Barricor tube evalua-
tions were performed, mostly encompassing sam-
ples from healthy participants (4,7,13-15). Never-
theless, to the best of our knowledge, this is the 
first study evaluating BD Barricor tubes in relation 
to BD RST tubes in terms of analytes’ comparabili-
ty and long-term stability of 25 analytes from in-
patient samples. Such approach provided real hos-
pital conditions ensuring a broad measuring range 
and finally obtaining a reliable bias and impreci-
sion results.
Analyte results comparison given from both tubes 
were in line with our expectations and in agree-
ment with previous examinations comparing se-
rum and plasma specimen results (9,14-16). Kosem 
et al. compared eight biochemistry tests from BD 
RST and BD Barricor tubes with the BD Serum Sep-
arator Tubes (SST) as reference tubes (16). Their 
study was performed in haemodialysis patients. 
By comparing BD SST with BD Barricor tubes, they 
obtained an unacceptable bias for K and AST. An-
other recently published study by Arslan et al. 
along with K, reported an unacceptable bias for 
Analyte, 
unit N BD RST 0
BD RST 7 
days
Imprecision 
(%) BD Barricor 0









52 66.4 ± 7.7 66.1 ± 7.5 - 0.20 69.1 ± 7.2 69 ± 7.1 - 0.58 1.30
Albumin, 
g/L 52 37.4 ± 6.7 37.2 ± 6.8 - 0.55 37.4±6.4 36.5 ± 7.5 - 1.99 1.30
CRP, mg/L 52 6.6 (3.1-12-5) 6.1 (3.0-13.3) - 0.62 6.6 (3.0-12.3) 6.1 (3.0-13.3) - 0.98 16.75
Bilirubin, 
μmol/L 52 12 (10-14) 11 (10-13) - 7.60 12 (10-14) 11 (10-13) - 6.69 10.90
















(45-81) - 2.71 7.00













(3.43-4.13) - 1.83 3.00







Data are presented as mean ± standard deviation, and median (interquartile range).  PB - Passing-Bablok. CI - confidence interval. 
CK - creatine kinase. CK-MB - creatine kinase isoenzyme MB. AST - aspartate aminotransferase. ALT - alanine aminotransferase. 
ALP - alkaline phosphatase. LD - lactate dehydrogenase. GGT – gamma-glutamyltransferase. CRP - C-reactive protein. TnI - troponin I. 
TSH - thyroid-stimulating hormone. fT3 - free triiodothyronine. fT4 - free thyroxine.
Table 4. Continued.
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AST, LD and glucose in BD Barricor compared to 
serum samples (9). Difference in K concentration 
between plasma and serum tubes was observed 
in all mentioned studies (bias ranged from - 4.9 up 
to - 7.1%) and it was similar to the findings in our 
study (9,14-16). Our study, together with all men-
tioned studies, found a higher bias for K than the 
one stated for desirability in both the EFLM Biolog-
ical Variation Database or Westgard’s database 
(11,12). In literature, higher K concentration in se-
rum when compared to plasma, is mostly attribut-
ed to the release of K from platelets during plate-
let aggregation and degranulation in the clotting 
process, and this can probably be attributed to our 
study.
Positive bias for total protein in BD Barricor was 
also in accordance with other studies’ reports 
where bias ranged from 3.9 to 5.2% and could be 
explained with the presence of fibrin and fibrino-
gen in plasma samples that are also measured in 
the spectrophotometric reaction for total protein 
(6,9).
Unacceptable differences after a 24-hour storage 
period, in comparison to the baseline measure-
ments, were observed for glucose, AST and LD in 
BD Barricor, and for fFT3 in RST tubes. The findings 
in our research are consistent with other studies 
data. Demeester et al. investigated the stability of 
21 routine chemistry parameter in both S-Mon-
ovette lithium heparin and BD Barricor sample 
tubes at 5 different time points through 7 days 
(17). Imprecisions observed for glucose and AST af-
ter a 24-hour storage period were - 4.4% and 4.1%, 
respectively. Finally, these authors did not find un-
acceptable changes for LD (1.1%) after a 24-hour 
storage period. According to their data, accepta-
ble glucose analysis postponement, in both inves-
tigated plasma tubes, was only 6 hours. This was 
also in accordance with the results presented in 
the Brandhorst et al. study, where authors investi-
gated the stability of different clinical chemistry 
parameters in four different lithium heparin plas-
ma tubes (18). Their data show that the acceptable 
glucose analysis postponement was to be be-
tween 9 and 15 hours, depending on the tube 
used. Dupuy et al. investigated the stability of nine 
analytes in BD lithium heparin tubes and BD Barri-
cor tubes and they observed an AST activity in-
crease after a 24-hour storage period in both BD 
lithium heparin (4.4%) and BD Barricor (5.6%) 
tubes, which is consistent with our results (19).
After a 7-day storage period unacceptable differ-
ences in comparison to the baseline measure-
ments were observed for Na, K, Ca, CK-MB, AST, LD 
and TnI in both tubes, while for glucose, ALP and 
albumin in BD Barricor samples only, what is 
shown to be consistent with the results of other 
studies. Demeester et al. reported similar results 
after a 7-day storage period in BD Barricor plasma 
tubes for albumin, ALP, AST, glucose, LD, Na and K 
(17). Shimizu et al. obtained results comparable to 
ours for AST and LDH in serum samples after stor-
ing samples for 7 days on 4 °C (20). 
As described in literature, serum displays a better 
sample stability compared to plasma (4). This is 
mostly attributed to blood cells remaining in plas-
ma in higher concentration than in serum. Since 
AST and LD are present in cells, and glucose is a 
substrate of many cellular enzymes, the above-
mentioned time-dependent stability point of is-
sue may be caused by incomplete blood cell sepa-
ration during the centrifugation process and sub-
sequent blood cell lysis and releasing of intracellu-
lar content during the storage periods. This as-
sumption is partially supported in the Dimeski et 
al. study, where authors demonstrated that BD 
Barricor tubes had a higher white blood cell count 
and markedly higher platelet count compared to 
the RST tubes (21). These findings could also ex-
plain higher AST and LD activities and lower glu-
cose concentration in BD Barricor when compared 
to serum samples, as reported by the Arslan et al. 
study (9).
Passing-Bablok regression revealed no significant 
difference between results for majority of ana-
lytes. Proportional differences obtained for some 
analytes (ALP, LD, GGT, total protein, albumin and 
fT4) were small in magnitude (slope ranged from 
0.93 to 1.04), and could not result in the concentra-
tion difference higher than the desirable specifica-
tion for total allowable error according to the 
Westgard’s database, with the exception of total 
protein. As for systematic differences, the ones ob-
Biochem Med (Zagreb) 2020;30(3):030704  https://doi.org/10.11613/BM.2020.030704 
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tained for GGT, albumin and even fT4 (intercept 
ranged from - 0.74 to 1.59) were practically negligi-
ble. Significant systematic differences obtained for 
LD and total protein could be attributed to the al-
ready explained mechanisms (release of intracellu-
lar enzymes from residual blood cells during cen-
trifugation for LD and presence of fibrin and fibrin-
ogen for total protein).
Differences in fT3 concentration, after a 24-hour 
storage period, in RST tube is difficult to comment 
because we could not find other studies that were 
assessing fT3 stability in serum samples. Also, 
there is no consistency in fT3 stability at the two 
observed time points, because calculated impreci-
sion after 7 days was found to be lower than the 
calculated imprecision after a 24-hour period. Be-
sides, the desirable imprecision value, namely 
3.0%, was calculated from the EFLM Biological Var-
iation Database, while the desirable imprecision 
for FT3 in the Westgard’s database is found to be 
4.0%.
It should be noted that our research has some limi-
tations. Insufficient sample size for TnI due to the 
large proportion of patients with values below the 
LoD is one of the main shortcomings of our study. 
Additional limitation is the sample stability meas-
urement at only two time-points. If we had com-
prised more time points in our study, we would be 
able to estimate time-dependent analyte stability 
more accurately. It should also be emphasized that 
the initial tubes draw volumes were not the same 
(5 mL for RST and 4.5 mL for Barricor). Also, we are 
aware that BD RST can be centrifuged at 4000xg 
for 3 minutes, same as BD Barricor (8). Although it 
would be better to make a comparison under the 
same centrifugation conditions, we opted for the 
centrifugation conditions of BD RST tubes accord-
ing to our previous routine protocols. Still, since 
the minimum recommended clotting time for BD 
RST is 5 minutes, BD Barricor can contribute to im-
proving laboratory performance by 5 minutes 
considering it can be centrifuged immediately.
In conclusion, BD Barricor tubes showed compara-
ble results for almost all analytes, when compared 
to BD RST tubes, with the exception of K and total 
protein. Hence reference intervals for K and total 
protein should be adapted according to the sam-
ple type. All other analytes can be measured inter-
changeably, applying the same reference inter-
vals. For most of the examined analytes, sample 
re-analysis can be performed in both tubes after 
24 hours. If necessary, re-analysis can be per-
formed in BD Barricor tubes after 7 days for most 
of the analytes, although BD RST tubes show bet-
ter 7-day analytes stability over BD Barricor tubes. 
An advantage of BD Barricor tubes over BD RST 
tubes is an improved laboratory workflow due to 
the possibility of immediate centrifugation.
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